GSK1349572 Drug Interaction With Tenofovir

Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV

NCT01125696 ·Status: COMPLETED ·Phase: PHASE2

Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use

NCT01421368 ·Status: COMPLETED ·Phase: PHASE1

CROSSOVER STUDY OF ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIR

NCT06560684 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing Tenofovir

NCT03670355 ·Status: COMPLETED ·Phase: PHASE1

A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection

NCT00002453 ·Status: COMPLETED ·Phase: NA

Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women

NCT00705679 ·Status: COMPLETED ·Phase: PHASE2

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

NCT01386294 ·Status: COMPLETED ·Phase: PHASE3

A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals

NCT00000772 ·Status: COMPLETED ·Phase: PHASE1

Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

NCT00592124 ·Status: COMPLETED ·Phase: PHASE2

Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression

NCT00344981 ·Status: COMPLETED ·Phase: NA

Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients

NCT00358696 ·Status: COMPLETED ·Phase: PHASE4

Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone

NCT02235662 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients

NCT00002450 ·Status: COMPLETED ·Phase: PHASE3

Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.

NCT01565889 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

NCT01721109 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks

NCT00001063 ·Status: COMPLETED ·Phase: PHASE2

PK and PD Study of Oral F/TAF for HIV Prevention

NCT02904369 ·Status: COMPLETED ·Phase: PHASE1

Comparison of Tenofovir Vaginal Gel and Film Formulations

NCT02280109 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia

NCT00078182 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

Tenofovir Pharmacology in Older HIV Infected Individuals

NCT02304263 ·Status: COMPLETED

Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men

NCT00131677 ·Status: COMPLETED ·Phase: PHASE2

Safety, PK, and PD Study of IVRs Releasing TFV and LNG

NCT03279120 ·Status: COMPLETED ·Phase: PHASE1

Exploratory Pharmacodynamic Study of Tenofovir-Based Products

NCT02722343 ·Status: COMPLETED ·Phase: PHASE1

Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF)

NCT03126370 ·Status: COMPLETED ·Phase: PHASE4

A Study of Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) and MK-8527 in Healthy Participants

NCT06816043 ·Status: COMPLETED ·Phase: PHASE1